Download presentation
1
CONTRAST MEDIA Dr. Ahmed Refaey FRCR
13
Types of contrast media
* Iodinated : * HOCM * LOCM * GIT contrast agents * Barium sulphate * water soluble contrast media ( Gastrographin) * MRI contrast agent * Ultrasound contrast agent
14
IODINATED CONTRAST AGENTS
15
Classification High osmolar contrast agents ( HOCA )
Low osmolar contrast agents ( LOCA ) * Ionic * Non-ionic
16
HOCM HOCA are in use since the 1950. * Urovist. * Urogarfin
* Angiovist. * Conray. * Renografin. * Renovist. * Hypaque.
17
LOCA Non-ionic Ionic Ultravist Omnipaque Visipaue Oxilan Hexabrix
18
LOCA have a lower incidence of adverse reactions by a factor of 6 for all reactions , and by a factor of 9 for the severe reactions.
19
Toxic effects Vascular toxicity Soft tissue toxicity
Cardiovascular toxicity Haematological changes Thyroid function Nephrotoxicity
20
Nephrotoxicity Incidence of contrast induced nephrotoxicity 5%
In the majority, renal impairment is temporary Predisposing factors : * impairment of renal function * DM * dehydration * old age * large doses of CM * multiple myeloma
21
Reactions of CM Fatal reactions ( death ) -1/140,000 for HOCM
1/300,000 for LOCM -occur in minutes -old age -causes ( cardiac arrest – pulmonary edema – respiratory arrest – coagulopathy – laryngeal edema- bronchospasm )
22
Non- fatal reactions 1-flushing, metallic taste in the mouth, nausea, sneezing, cough—common & related to dose and speed of injection. 2- urticaria 3- angioneurotic edema 4- bronchospasm 5- pulmonary edema 6- arrythmia 7- hypotension 8- delayed reactions: rashes , headaches, itching
23
*Excluding death, adverse reactions can be classified in terms of severity as:
1- major reactions : those that interfere with the examination and require treatment. 2- intermediate reactions : those that interfere with the examination but do not require treatment. 3- minor reactions : those that do not interfere with the examination and require only assurance
24
Risk factors allergy , asthma Cardiac disease Hepatic failure
Poor hydration Co-administration of: glucophage Previous reaction to contrast media - HOCM % - LOCM % Other factors: * pheochromocytoma * sickle cell disease * hyperprotinemia ( multiple myeloma )
25
High risk patients should either:
1 – be premeicated with steroids 2- to be evaluated with other modality ( U/S – MRI )
26
Route of administration : intravenous
Uses : * CT study * urography ( IVP- urethrography_ cystography ) * angiography ( arteriography – venography ) * PTC, ERCP, T-tube cholangiography * hystrosalpingography * sialography * fistulography
27
Urography
28
IVU
29
Cystogram
32
Urethrogram
33
Angiography
35
Sialogram
36
Sialogram
37
Fistulogram
38
PTC
39
PTC
40
ERCP
41
T-tube cholangiogram
42
HSG
43
HSG
44
GIT contrast agents
45
Gastrointestinal contrast agents
BARIUM SULPHATE WATER SOLUBLE CONTRAST MEDIUM (GASTROGRAFIN )
47
BARIUM SULPHATE
48
Barium sulphate Thin barium : for upper GI studies, small bowel follow through, barium enema % BaSO4 solution. Thick barium : for double contrast studies % BaSO4 solution
49
Advantages : * excellent coating, allowing the demonstration of normal and abnormal mucosal patterns. * cost
51
Complications: Exacerbation of GI obstruction above a preexisting bowel obstruction Intraperitoneal extravasation through gut perforation results in extensive fibrosis
52
Contraindication : Bowel obstruction Bowel perforation
53
Water soluble contrast medium (gastrografin )
54
Water soluble contrast medium (Gastrografin )
Oral contrast medium for opacification of GIT Hygroscopic agent Undiluted or diluted Can be used as a substitute for barium if GI perforation is suspected. In CT , diluted by 1:40
55
Complications Aspiration can cause chemical pneumonitis Diarrhea
Hypovolemic shock if used undiluted
66
CT contrast agents IV contrast medium
Oral water soluble contrast medium (gastrografin)
72
MRI contrast agent
73
MRI contrast agent Gadolinium Gd-DTPA IV
76
ULTRASOUND CONTRAST AGENT
Levovist / echovist IV
79
Thank you
80
All agents consist of radiodense iodinated Benzene ring.
Ionic agent typically formulated as Sodium and or meglumine salts.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.